A deep-to-understand overview of Kirin Group by 5 keywords Key Topics Crysvita® (burosumab) now launched in the U.S. and Europe The Lactococcus lactis strain Plasma anti-viral immune system Kirin Beverage initiatives for sales via vending machines Read more Dividend and Stock Information Dividend Payment and Own-share RepurchaseStock InformationShare Data IR Events General Meeting of Shareholders Management & History Message from President & CEOHistory Quick Links KIRIN REPORT [Integrated Report] Environmental ReportKirin Group Long-Term Environment Vision Contact Us FAQsIR Ccontacts